Blood Test May Help Identify Which Colorectal Cancer Patients with Liver Metastases Are Most Likely to Benefit from Chemotherapy After Surgery
Date: 03 Jul 2026 Munich, Germany – A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers...
ESC Congress 2026: Transforming innovative ideas into clinical reality
Key takeaways The world's leading cardiology experts will convene in Munich for ESC Congress 2026. The event takes place from 28 to 31 August, with the press programme beginning on 27 August. This year’s spotlight on artificial intelligence will explore the potential...
Common food preservatives linked to high blood pressure and heart disease
Key takeaways The study of 112,395 people includes a detailed analysis of diet and food ingredients. Researchers found eight preservative food additives linked to high blood pressure or cardiovascular disease. The highest risks were in people who ate the most...
Experts call for women’s heart centres to tackle inequality in diagnosis & care
Key takeaways: Cardiovascular disease is the leading cause of death in women. Women are more likely to have undiagnosed and untreated cardiovascular disease. Dedicated women's heart centres are needed to improve diagnosis, treatment and care. Sophia Antipolis,...
ESMO Breast Cancer 2026 – Precision Oncology, Molecular Monitoring and the Evolving Paradigm of Survivorship Care
The scientific programme of ESMO Breast Cancer 2026 highlighted the accelerating integration of precision oncology into breast cancer prevention, disease monitoring, and survivorship care. Across sessions dedicated to early detection, translational research, and early...
Opening Ceremony of ESMO Breast Cancer 2026 Sets the Tone for Innovation and Global Collaboration
The ESMO Breast Cancer 2026 officially commenced on Wednesday, May 6, with a distinguished opening ceremony and award lecture that underscored the rapid pace of scientific advancement and the critical role of international collaboration in improving breast cancer...
European Lung Cancer Congress 2026 Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows in China
COPENHAGEN, Denmark, 27 March 2026 – New evidence from a Chinese cohort presented today at the European Lung Cancer Congress (ELCC) 2026 shows that onetime lowdose computed tomography (LDCT) screening can significantly reduce lung cancer mortality in a...
The Power of the Heart Team: Advancing Acute Cardiovascular Care Together ESC Acute CardioVascular Care 2026 to take place in Lisbon
Key takeaways ESC Acute CardioVascular Care 2026 (#ACVC26), the annual meeting for acute cardiovascular care professionals, will take place 20–21 March 2026 in Lisbon, Portugal. The two-day program features nearly 100 scientific sessions covering the full spectrum of...
ESC launches guidelines for patients to empower women with cardiovascular disease to make informed pregnancy health decisions
Key takeaways A new patient version of ESC Guidelines on pregnancy is being published on International Women’s Day to empower women living with cardiovascular disease to make informed decisions about pregnancy and birth and support shared decision making with...
Interview with Dr. Christopher M. Kramer, MD President of the American College of Cardiology. Lack of awareness is a major challenge in addressing environmental risk factors
The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. Since 1949, the ACC has served as the preeminent source of professional medical education for the entire cardiovascular care team,...
Interview with Professor Thomas F. Lüscher, MD, FRCP, FESC, President of the European Society of Cardiology (ESC). International statement issued by ESC, ACC, AHA and WHF: The heart does not exist in isolation – it beats within an ecosystem
In January 2026, the world’s leading cardiovascular organisations—the European Society of Cardiology (ESC), the American College of Cardiology, the American Heart Association and the World Heart Federation—issued their first-ever joint statement calling for urgent...
International statement issued by ESC, ACC, AHA and WHF – The heart does not exist in isolation – it beats within an ecosystem
Interview with Professor Thomas F. Lüscher, MD, FRCP, FESC President European Society of Cardiology (ESC) In January 2026, the world’s leading cardiovascular organisations—the European Society of Cardiology (ESC), the American College of Cardiology, the American Heart...
Education and research on cardiovascular interventions reach new heights at the first EAPCI Summit
The first official summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) organised directly under the umbrella of the European Society of Cardiology (ESC) will take place in Munich, Germany on 19–20 February 2026. Percutaneous...
Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off
Source ESMO 19 Jan 2026 After increasing for more than 25 years, lung cancer death rates are finally levelling off among women in European Union (EU) countries apart from Spain, according to predictions of mortality rates from the disease for 2026. In the UK, death...
Global societies unite to address environmental threats to heart health
Source - The European Society of Cardiology (ESC) 20 January 2026 The world’s leading cardiovascular societies, the European Society of Cardiology (ESC), the American College of Cardiology (ACC), the American Heart Association and the World Heart Federation (WHF)...
Valvular heart disease is common in cancer patients but interventions improve survival
Vienna, Austria – 11 December 2025: Valvular heart disease, identified through cardiovascular imaging, is common in cancer patients. Interventions to treat valvular heart disease significantly improved survival.1 These findings were presented today at EACVI 2025, the...
AI-based tool predicts future cardiovascular events in patients with angina
Vienna, Austria – 11 December 2025: Measured using an artificial intelligence-based imaging tool, reduced coronary blood flow predicted future cardiovascular events in patients with suspected stable coronary artery disease.1 These findings were presented today at...
Fat tissue around the heart may contribute to greater heart injury after a heart attack
Vienna, Austria – 12 December 2025: Increased volume of epicardial adipose tissue, detected by cardiovascular imaging, was found to be associated with greater myocardial injury after a myocardial infarction.1 These findings were presented today at EACVI 2025, the...
New European Research Institute on Simulation (ERIS) to coordinate currently fragmented simulation training and education across Europe
There is a pressing need for academically driven simulation training across Europe. To address this gap, the European Union’s Horizon Programme is funding the European Research Institute on Simulation (ERIS) project, aiming to coordinate the simulation-based training...
First ever ESC Digital & AI Summit to take place in Berlin in November
Embracing the new era in digital cardiology and all the potential it offers, the European Society of Cardiology (ESC) will host its first ever Digital & AI Summit in Berlin, Germany, from November 21–22. Cardiology professionals, technology experts, and other key...
ESMO Congress 2025: ESMO publishes first guidance on the safe use of Large Language Models in oncology practice
New framework aims to help patients, clinicians and institutions adopt AI language tools responsibly Lugano/Berlin, 18 October 2025 – The European Society for Medical Oncology (ESMO) released today the ESMO Guidance on the Use of Large Language Models in Clinical...
ESMO Congress 2025
Lugano, Switzerland – The ESMO Congress 2025 will take place from 17-21 October in Berlin, Germany, where internationally renowned oncology experts will present cutting-edge data and engage in thought-provoking discussions covering the current advances and future...
TO_AITION project takes significant steps toward bridging the gap between cardiovascular disease and mental health
Key takeaways Depression affects 300+ million people and increases the risk of cardiovascular disease (CVD) and mortality by two to three times. One in three CVD patients experiences depression; one in two develops it after major cardiac events. The conditions are...
Record-Breaking ESC Congress in Madrid welcomed over 33,000 participants
Over 33,300i healthcare professionals from 169 nations took part in the European Society of Cardiology’s flagship meeting ESC Congress in Madrid. The world’s leading event in cardiovascular medicine was held in partnership with the World Heart Federation and focused...
2025 ESC Guidelines for the management of cardiovascular disease and pregnancy
Today, Professor Julie De Backer (Ghent University Hospital - Ghent, Belgium) and Professor Kristina H. Haugaa (Oslo University Hospital - Oslo, Norway) presented new guidelines on cardiovascular disease (CVD) and pregnancy,1 with a shift in clinical focus on various...
World Heart Federation honors American Heart Association CEO for lifetime of impact
American Heart Association CEO Nancy Brown to receive honor August 29 in Madrid as part of the European Society of Cardiology annual conference DALLAS and MADRID, August 26, 2025 — The World Heart Federation (WHF) is set to honor Nancy Brown, chief executive...
Walking further and faster is linked to a reduced risk of heart attacks, heart failure and stroke in people with high blood pressure
Even walking fewer than 10,000 steps a day reduced the risk Key takeaways: Taking more steps, even below the recommended daily target of 10,000 steps, and walking faster, significantly lowers the risk of major problems of the heart and blood vessels in people with...
The effectiveness of turmeric and fiber supplement in improving the symptoms of hemorrhoidal disease
Doina Istratescu1, 2, *, Rucsandra Diculescu1, 2, Tudor Stroie1, 2, Corina Meianu1, 2, Codruta Delia Radu2, Cristian George Gogarla2, Roxana Lucuta1, 2 and Mircea Diculescu1, 2 1 UMF „Carol Davila” Gastroenterology&Hepatology Department, Fundeni Clinical...
Diabetic polyneuropathy does not exclusively start with small fiber damage, is not invariably progressive and may even regress: a prospective study from the GDS group
Aim: To assess whether small and large fibre damage due to diabetic sensorimotor polyneuropathy (DSPN) in type 1 (T1D) and type 2 diabetes (T2D) could develop in parallel and whether it may be reversible. Methods: Prospective observational study of subjects from...
The pandemic is still here this year and will continue to challenge us on all levels
Interview with Sévan Kaloustian Managing Director Janssen, Administrator Johnson & Johnson RomaniaJohnson& Johnson has a long standing history. What is the company’s commitment? The company’s long standing history is more of a heritage, as well as a living...
We will continue to invest in new therapies
Interview with Jorge Levinson Country Commercial Lead Bayer Pharmaceuticals Romania &Moldova How was 2020 for BAYER in Romania? Was there a growth in business? Clearly, 2020 will be remembered as the year when humankind was threatened by a virus. It was a...